Quantification of the placebo response in ulcerative colitis.
about
Placebo effects: clinical aspects and neurobiologyIncreasing fecal butyrate in ulcerative colitis patients by diet: controlled pilot studyRosiglitazone for active ulcerative colitis: a randomized placebo-controlled trial.Placebo effect in the treatment of duodenal ulcer.[Placebo response: in studies on pain and under other clinical conditions].Treatment with neurokinin-1 receptor antagonist reduces severity of inflammatory bowel disease induced by Cryptosporidium parvum.Placebo responses in patients with gastrointestinal disordersQuality of life of breast cancer patients medicated with anti-estrogens, 2 years after acupuncture treatment: a qualitative studyPlacebo response in the prophylaxis of migraine: a meta-analysis.Meta-analysis: the effects of placebo treatment on gastro-oesophageal reflux disease.Age and sex as moderators of the placebo response – an evaluation of systematic reviews and meta-analyses across medicineTegaserod and IBS: a perfect match?Systematic Review and Meta-analysis: Placebo Rates in Induction and Maintenance Trials of Ulcerative Colitis.Restraint stress induces and exacerbates intestinal inflammation in interleukin-10 deficient mice.Radiofrequency Ablation Is Associated With Decreased Neoplastic Progression in Patients With Barrett's Esophagus and Confirmed Low-Grade DysplasiaState of the art: IBD therapy and clinical trials in IBD.Outcomes of placebo therapy in inflammatory bowel disease.A meta-analysis of the placebo response in complementary and alternative medicine trials of irritable bowel syndrome.The placebo response in clinical trials: more questions than answers.Treatment of IBD: where we are and where we are going.Placebo effects and their determinants in gastrointestinal disorders.Fluoxetine inhibits NF-κB signaling in intestinal epithelial cells and ameliorates experimental colitis and colitis-associated colon cancer in mice.Use of the noninvasive components of the Mayo score to assess clinical response in ulcerative colitis.Evaluation of responsive gene expression as a sensitive and specific biomarker in patients with ulcerative colitis.Evidence-based clinical practice guidelines for functional dyspepsia.Acupuncture and moxibustion in the treatment of ulcerative colitis: a randomized controlled study.Induction and maintenance of clinical remission by interferon-beta in patients with steroid-refractory active ulcerative colitis-an open long-term pilot trial.
P2860
Q24653735-6843C388-40D8-42A5-9E1C-7AC578E37A37Q28206907-44A461C5-7BF5-4DC0-AEA7-6DCAE919273CQ30440147-9F80A661-74A9-4752-B9CA-01DB24A6A21CQ33792407-C33ED496-5ED4-4B21-8C77-245AFF9D47AFQ33938286-A7C5792B-A22F-4587-8194-AEE76230719AQ33942506-B2C68A1A-52A7-475E-8044-CFF0852C3202Q34098616-0DDCFA32-6664-4FA8-B559-EEF8BB33A29CQ34345677-6A307E3F-D3DB-43AF-AAFC-C53511EB6E41Q34621702-8DC513EC-CF57-452B-B43A-CF469F4F809CQ35147233-1B1B2DD8-C06E-4E30-9F57-54B7F71893F6Q35513153-41DA923A-DA89-4930-87F0-466A9C5966B6Q35595588-0A0092AE-DEFF-444E-917B-D72BD98C8082Q35889006-88D3D63F-2770-4BE2-BF72-EFA5AF5FCC96Q35891396-8D012667-55EE-4230-9357-9CA9DFDD7457Q35998193-9402AD04-9AF4-48D0-ADB7-8122DE200362Q36299319-48AD1E90-2EEC-4630-A73E-42EDD55F7796Q36457551-81D43370-CFCA-4734-A5B5-1FA994D107C6Q36886282-2408D26F-E13C-48E9-95A1-2640345C7B6FQ37876002-F46EF05D-32E9-47E4-A71A-74E1C2C9C0F2Q38285619-DB4D41BA-5D5B-40B3-B102-30852A890FF6Q38551120-CD375967-5652-4887-8B88-56FE6C914F7DQ39570966-8A7CCF3C-0FF6-4EB8-B287-FA3278F19A8EQ41128447-71693B98-EEDE-4DDF-AB67-4704FF6BEC24Q43873083-B6D49E52-E267-4119-A122-D25D25CE401CQ50977089-77AA08AF-88EA-4B2A-B8D2-75F56E9C6EF8Q53228723-B64157CF-3B92-4946-9032-67B3B68D3CE5Q53867994-4BE07BCF-5887-4EBD-A65D-B36856E24E16
P2860
Quantification of the placebo response in ulcerative colitis.
description
1997 nî lūn-bûn
@nan
1997 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Quantification of the placebo response in ulcerative colitis.
@ast
Quantification of the placebo response in ulcerative colitis.
@en
Quantification of the placebo response in ulcerative colitis.
@nl
type
label
Quantification of the placebo response in ulcerative colitis.
@ast
Quantification of the placebo response in ulcerative colitis.
@en
Quantification of the placebo response in ulcerative colitis.
@nl
prefLabel
Quantification of the placebo response in ulcerative colitis.
@ast
Quantification of the placebo response in ulcerative colitis.
@en
Quantification of the placebo response in ulcerative colitis.
@nl
P2093
P1433
P1476
Quantification of the placebo response in ulcerative colitis.
@en
P2093
P304
P356
10.1053/GAST.1997.V112.PM9178676
P407
P577
1997-06-01T00:00:00Z